The results of Alnylam Pharmaceuticals’ Phase 3 cardiovascular study was already...
The leading chronicler of presidents and health ponders the question: How old is...
Dorit Donoviel and her team at the Translational Research Institute for Space He...
The FDA's approval of Aurlumyn (ilosprost) culminates decades of research that h...
Dragonfly Therapeutics has entered a clinical collaboration with Gilead Sciences...
The US FDA has granted orphan drug designation to Ionis Pharmaceuticals’ olezars...
Xyphos Biosciences has entered an agreement with Kelonia Therapeutics to develop...
GSK has successfully concluded the acquisition of Aiolos Bio in a deal that coul...
The success of recent trials treating mental health problems with psychedelic th...
MYK-224 is under clinical development by Bristol-Myers Squibb and currently in P...
Despite failing its primary endpoint in the EMBARK confirmatory study, Elevidys’...
This positive news comes after Otsuka’s Phase III Alzheimer’s agitation trial fa...
Though the designation is for soft tissue sarcoma, tigilanol tiglate is in clini...
Regeneron and Sanofi's Dupixent has been approved for the treatment of chronic s...
A new CDC report shows Lyme disease cases rose by 69% in 2022 over previous year...
A recently unsealed lawsuit claims several large pharma companies that participa...
